Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
Mil Med. 2022 May 4;187(Suppl 2):42-51. doi: 10.1093/milmed/usab131.
During the wars in Iraq and Afghanistan, increased incidence of multidrug-resistant (MDR) organisms, as well as polymicrobial wounds and infections, complicated the management of combat trauma-related infections. Multidrug resistance and wound microbiology are a research focus of the Trauma Infectious Disease Outcomes Study (TIDOS), an Infectious Disease Clinical Research Program, Uniformed Services University, research protocol. To conduct comprehensive microbiological research with the goal of improving the understanding of the complicated etiology of wound infections, the TIDOS MDR and Virulent Organisms Trauma Infections Initiative (MDR/VO Initiative) was established as a collaborative effort with the Brooke Army Medical Center, Naval Medical Research Center, U.S. Army Institute of Surgical Research, and Walter Reed Army Institute of Research. We provide a review of the TIDOS MDR/VO Initiative and summarize published findings.
Antagonism and biofilm formation of commonly isolated wound bacteria (e.g., ESKAPE pathogens-Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.), antimicrobial susceptibility patterns, and clinical outcomes are being examined. Isolates collected from admission surveillance swabs, as part of infection control policy, and clinical infection workups were retained in the TIDOS Microbiological Repository and associated clinical data in the TIDOS database.
Over the TIDOS study period (June 2009 to December 2014), more than 8,300 colonizing and infecting isolates were collected from military personnel injured with nearly one-third of isolates classified as MDR. At admission to participating U.S. military hospitals, 12% of wounded warriors were colonized with MDR Gram-negative bacilli. Furthermore, 27% of 913 combat casualties with ≥1 infection during their trauma hospitalization had MDR Gram-negative bacterial infections. Among 335 confirmed combat-related extremity wound infections (2009-2012), 61% were polymicrobial and comprised various combinations of Gram-negative and Gram-positive bacteria, yeast, fungi, and anaerobes. Escherichia coli was the most common Gram-negative bacilli isolated from clinical workups, as well as the most common colonizing MDR secondary to extended-spectrum β-lactamase resistance. Assessment of 479 E. coli isolates collected from wounded warriors found 188 pulsed-field types (PFTs) from colonizing isolates and 54 PFTs from infecting isolates without significant overlap across combat theaters, military hospitals, and study years. A minority of patients with colonizing E. coli isolates developed subsequent infections with the same E. coli strain. Enterococcus spp. were most commonly isolated from polymicrobial wound infections (53% of 204 polymicrobial cultures). Patients with Enterococcus infections were severely injured with a high proportion of lower extremity amputations and genitourinary injuries. Approximately 65% of polymicrobial Enterococcus infections had other ESKAPE organisms isolated. As biofilms have been suggested as a cause of delayed wound healing, wound infections with persistent recovery of bacteria (isolates of same organism collected ≥14 days apart) and nonrecurrent bacterial isolates were assessed. Biofilm production was significantly associated with recurrent bacteria isolation (97% vs. 59% with nonrecurrent isolates; P < 0.001); however, further analysis is needed to confirm biofilm formation as a predictor of persistent wound infections.
The TIDOS MDR/VO Initiative provides comprehensive and detailed data of major microbial threats associated with combat-related wound infections to further the understanding of wound etiology and potentially identify infectious disease countermeasures, which may lead to improvements in combat casualty care.
在伊拉克和阿富汗战争期间,耐多药(MDR)生物体的发病率增加,以及多微生物伤口和感染,使创伤相关感染的治疗变得复杂。多药耐药性和伤口微生物学是创伤传染病结果研究(TIDOS)的一个研究重点,这是一个传染病临床研究计划,由美国武装部队大学统一服务大学进行,研究方案。为了进行全面的微生物学研究,旨在提高对伤口感染复杂病因的理解,TIDOS MDR 和毒力生物体创伤感染倡议(MDR/VO 倡议)成立了,作为与布洛克陆军医疗中心、海军医学研究中心、美国陆军研究所和沃尔特·里德陆军研究所合作的努力。我们提供了 TIDOS MDR/VO 倡议的审查,并总结了已发表的研究结果。
通常分离的伤口细菌(例如 ESKAPE 病原体-屎肠球菌、金黄色葡萄球菌、肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌属)的拮抗作用和生物膜形成、抗菌药物敏感性模式以及临床结果正在进行检查。从入院监测拭子中收集的分离物,作为感染控制政策的一部分,以及临床感染检查的分离物保留在 TIDOS 微生物库中,并在 TIDOS 数据库中保留相关的临床数据。
在 TIDOS 研究期间(2009 年 6 月至 2014 年 12 月),从受伤的军人身上收集了 8300 多个定植和感染的分离物,其中近三分之一的分离物被归类为 MDR。在参加美国军事医院的病人中,12%的伤员定植有 MDR 革兰氏阴性杆菌。此外,在 913 名有≥1 次感染的作战伤员中,有 27%的感染为 MDR 革兰氏阴性菌感染。在 335 例确诊的与作战相关的四肢伤口感染(2009-2012 年)中,61%为多微生物,由各种革兰氏阴性和革兰氏阳性细菌、酵母、真菌和厌氧菌组成。从临床检查中分离出的最常见的革兰氏阴性杆菌是大肠埃希菌,也是由于产超广谱β-内酰胺酶耐药而最常见的定植 MDR。从伤员中收集的 479 株大肠埃希菌分离物评估发现,定植分离物中有 188 个脉冲场型(PFT),感染分离物中有 54 个 PFT,在战斗地区、军事医院和研究年份之间没有明显重叠。少数定植大肠埃希菌分离物的患者随后感染了相同的大肠埃希菌株。肠球菌属最常从多微生物伤口感染中分离出来(204 株多微生物培养物中有 53%)。肠球菌感染的患者伤势严重,下肢截肢和泌尿生殖系统损伤的比例较高。大约 65%的多微生物肠球菌感染有其他 ESKAPE 生物体分离。由于生物膜已被认为是伤口愈合延迟的原因,因此评估了持续恢复细菌(在相隔≥14 天的时间收集相同的细菌分离物)和非复发性细菌分离物的伤口感染。生物膜的产生与复发性细菌分离显著相关(与非复发性分离物相比,97%与 59%;P<0.001);然而,需要进一步分析以确认生物膜形成是持续伤口感染的预测因子。
TIDOS MDR/VO 倡议提供了与作战相关伤口感染相关的主要微生物威胁的全面和详细数据,以进一步了解伤口病因,并可能确定传染病对策,这可能导致作战伤员护理的改善。